Cardiovascular diseases (CVDs) remain one of the major causes of mortality worldwide. In
response to this and other worldwide health epidemics, nanomedicine has emerged as a …

Atherosclerosis is the root of approximately one‐third of global mortalities. Nanotechnology
exhibits splendid prospects to combat atherosclerosis at the molecular level by engineering …

The oxygenation of polyunsaturated fatty acids such as arachidonic and linoleic acid
through lipoxygenases (LOX s) and cyclooxygenases (COX s) leads to the production of …

Objective This study was to investigate the mechanism of inflammatory pathology
modification induced by ox-LDL in endothelial cells. Methodology In this study, we firstly …

Background: Retinol-binding protein 4 (RBP4) is an adipokine that plays decisive roles in
glucose metabolism and insulin sensitivity. Elevated circulating RBP4 levels were reported …

Abstract Ethnopharmacological relevance The Tongmai Yangxin Pill (TMYX) is a patented
traditional Chinese medicine originating from two classic prescriptions, Zhigancao …

Atherosclerosis is universally recognized as a chronic lipid-induced inflammation of the
vessel wall in response to dyslipidemia and haemodynamic stress involving dysfunction and …

Short-chain fatty acids (SCFAs) are metabolites produced by gut bacteria and play a crucial
role in various inflammatory diseases. Increasing evidence suggests that SCFAs can …

Cardiovascular disease is one of the leading causes of death and disability in the world.
Atherosclerosis, characterized by lipid accumulation and chronic inflammation in the vessel …

Atherosclerosis is the primary cause of coronary heart disease (CHD), ischemic stroke, and
peripheral arterial disease. Despite effective lipid-lowering therapies and prevention …